Indications for use:
Diseases of the gastrointestinal tract, accompanied by a violation of the digestive capacity and a decrease in the acidity of gastric juice: gastritis (inflammation of the gastric mucosa), gastroenteritis (inflammation of the mucous membranes of the stomach and small intestine), enterocolitis (combined inflammation of the small and large intestine), etc. .
Combined product obtained from the gastric mucosa of calves and lambs of milk age. The drug has a proteolytic effect, normalizes the process of digestion. The digestive enzymes contained in the product retain their activity in a slightly acidic and neutral environment.
Abominum (Abomin) method of administration and dose:
Inside during meals, 1 tablet 3 times every day for 1-2 months; with insufficient effectiveness, a single dose is increased to 3 tablets, and the course of treatment is extended to 3 months. In acute gastritis, gastroenteritis, colitis, 1 tablet is prescribed 3 times every day for 2-3 days.
There are no data on drug interactions.
Abominum (Abomin) composition:
Yellowish-gray powder with a specific odor, salty taste (contains an admixture of NaCl).
Activity is determined by the biological method. 1 g contains 250,000 units.
1 tablet contains:
a complex of proteolytic (protein-splitting) enzymes (with a milk-curing activity of 50,000 units) – 200 mg.
In addition to the active substance (abomin), the composition of the product includes: calcium stearate, potato starch.
Moscow Plant of Rennet Ferment JSC (Russia);
Moskhimfarmprodukty Federal State Unitary Enterprise im. N.A. Semashko (Russia);
St. Petersburg NITI of antibiotics and enzymes for medical purposes (Russia);
State Research Institute for Standardization and Control of Medicinal Products of the Ministry of Health of Russia (Russia);